1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68AE4F71447EA3E670025876F004F051C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/8AE4F71447EA3E670025876F004F051C?OpenDocument
18
19OpenDocument
2034.239.151.124
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Quality, Compliance and Regulatory Regulatory Affairs

Document Excerpt: Navigating the Challenges and Costs of the new European Union Medical Device Regulation (EUMDR): Cost Impact by Company EU Revenue Level, TA/Condition and Implementation Activities

DB Image

ID: MD-799


Features:

10 Info Graphics

17 Data Graphics

150+ Metrics


Pages/Slides: 4


Published: 2021


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5699 “Navigating the Challenges and Costs of the new European Union Medical Device Regulation (EUMDR): Cost Impact by Company EU Revenue Level, TA/Condition and Implementation Activities”.

Industries Profiled:
Medical Device; Technology; Pharmaceutical; Health Care; Science; Manufacturing; Research; Diagnostic


Companies Profiled:
Becton Dickinson; RaySearch Laboratories; Medtronic; Zap; Teleflex; SinuSys; Cardinal Health; Atos; Boston Scientific; Rhythmlink; Thermo Fisher; Celo Nova; ConMed Corporation; Kestra; Zimmer Biomet; Xodus Medical; 3M Company; Establishment Labs; inStem; Aqualizer; Avanos Medical; Ascensia; Needle Tech Products; Dentsply Sirona; Foundation Medicine

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.